BioRestorative Therapies Inc expected to post a loss of $1.19 a share - Earnings Preview

Biorestorative Therapies

12/08/2023 03:06

* BioRestorative Therapies Inc  BRTX.OQ   BRTX.O  is
expected
to show a fall in quarterly revenue when it reports  results on
August 15 (estimated). 
    * The Melville New York-based  company is expected to report
 a
78.9% decrease in revenue to $15 thousand from $71.1 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BioRestorative
Therapies
Inc is for a loss of $1.19 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
BioRestorative
Therapies Inc is $12.5​, above​ its last closing price of $2.59.
​​​

This summary was machine generated August 12 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated